Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Global Forecast to 2028

Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Global Forecast to 2028

The global clinical trial supplies market size is projected to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9% during the forecast period. Factors such as Increasing number of clinical trials, Growing product pipeline, and Increasing decentralization of clinical trials are likely to have positive impact on the market growth.

“The logistics and distribution segment held the dominant share in the clinical trial supplies market”

Based on services, the global clinical trial supplies market is segmented into pathogen component, adjuvant emulsions, particulate adjuvants, saponin-based adjuvants and other adjuvants. The adjuvant emulsions segment held a dominant share in the market in 2022. Extensive use of adjuvant emulsions in COVID-19 & other infectious diseases and the rising prevalence of contagious diseases are likely to have positive impact on the growth of the market.

“Phase II segment accounted for the largest share of the phase segment in 2022.”

Based on phase, the clinical trial supplies market is segmented into phase I, phase II, phase III, phase IV, BA/BE studies. In 2022, the phase II segment accounted for the largest share of the clinical trial supplies market. The segment held the dominant share in the market owing to various factors such as increasing the number of registration in clinical trials and the rising R&D investment by pharmaceutical and biotechnologies company for new cancer drug development.

“Asia Pacific region is likely to grow at a faster pace in the clinical trial supplies market.”

The clinical trial supplies market region is segmented into North America, Europe, Asia Pacific, Latin America Middle East and the Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by the increasing number of registered clinical trials. The increasing decentralization of clinical trials from China, India, and Japan due to presence of prominent players are engaged in providing services for clinical trial, supports market growth in the Asia Pacific.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 80%, and Demand Side - 20%

By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%

By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc. (US)

Catalent, Inc. (US)

Eurofins (France)

Piramal Pharma Solutions (India)

PRA Health Sciences (Subsidiary of Icon Plc) (US)

Marken (Subsidiary of UPS) (US)

Parexel International (MA) Corporation (US)

Biocair (UK)

Almac Group (UK)

Sharp Services, LLC (US)

PCI Pharma Services (US)

Nuvisan (Germany)

Lonza Group (Switzerland)

OCT Group LLC. (Latvia)

Corex Logistics (Ireland)

Acnos Pharma GMBH (Germany)

Clinical Services International (UK)

KLIFO A/S (Denmark)

Clinigen Limited (UK)

Ancillare LP (US)

N-SIDE (Belgium)

ADAllen Pharma (UK)

Durbin ( Part of the Uniphar Group) (UK)

Recipharm AB (Sweden)

IPS Pharma (UK)

Research Coverage:

This report provides a detailed picture of the clinical trial supplies market. It aims at estimating the size and future growth potential of the market across different segments, such as service, phase, type, therapeutic area, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies, Increasing number of clinical trials, Growing decentralization of clinical trials, Rising prevalence of orphan and rare diseases, Increasing outsourcing activities in emerging Asian economies), restraints ( High cost of drug development), opportunities (Growth opportunities in emerging markets, Increased investments in development of biologics and biosimilars, Rising demand for specialized testing services) and challenges (High Cost of Clinical Trials) are influencing the growth of clinical trial supplies market.

Service Development/Innovation: Detailed insights on newly launched services of the clinical trial supplies market.

Market Development: Comprehensive information about lucrative markets – the report analyses the clinical trial supplies market across varied regions.

Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the clinical trial supplies market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include Thermo Fisher Scientific Inc. (US), Marken (US), Catalent, Inc. (US), Eurofins Scientific (France), and PRA Health Sciences (US), Parexel International (MA) Corporation (US), Biocair (UK), AlmacGroup (UK), Piramal Pharma Solutions (India), Sharp Services, LLC (US), PCI Pharma Services (US),